Clinical Trials on Major Depressive Disorder (MDD)

Total 9188 results

Associacao para Investigacao e Desenvolvimento...
University of Lisbon; Fundação para a Ciência e a Tecnologia; Instituto Politécnico...

Recruiting

Influence of Nutrition in Depression Treatment (INDEPT) (INDEPT)

Major Depressive Disorder - MDD

Portugal
Luye Pharma Group Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

China
The University of Hong Kong

Completed

Effectiveness of Walking Exercise in Improving Depression in Older Adults With Major Depressive Disorder, A Pilot Study

Major Depressive Disorder (MDD)

Hong Kong
Assurex Health Inc.
University of Michigan

Completed

Genomics Used to Improve DEpression Decisions (GUIDED)

Major Depressive Disorder (MDD)

United States
Shanghai Mental Health Center
Su Zhou YiHua Biotechnology Co. LTD

Completed

Comparison of Anyu Peibo With Placebo in Treatment of MDD

Major Depressive Disorder (MDD)

China
Wave Neuroscience

Completed

Feasibility Study to Test Clinical Efficacy of Low Energy AC Magnetic Field to Treat Major Depression

Major Depressive Disorder (MDD)

United States, China
Eli Lilly and Company

Completed

A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Major Depressive Disorder (MDD)

United States, Puerto Rico, Finland, Japan, Slovakia, Czechia, Croatia
Central South University

Unknown

Effect of Short-Term Mindfulness-Based Training For Major Depression Disorder: An Eye-Tracking Study

MDD

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of HS-10353 in Adult Participants With Major Depressive Disorder

Major Depressive Disorder (MDD)
Chase Therapeutics Corporation

Active, not recruiting

A Study in Patients With Major Depressive Disorder

Major Depressive Disorder (MDD)

United States
Shanghai Mental Health Center
Kun Ming KingBio Biotechnology Co. LTD

Completed

Comparison of Orcinoside With Placebo in Treatment of MDD

Major Depressive Disorder (MDD)

China
Section for Affective Disorders; Northern Stockholm...
Karolinska Institutet; Vastra Gotaland Region; Region Örebro County; Uppsala University...

Not yet recruiting

Cancer Related Major Depression Treated With a Single Dose of Psilocybin (CAPSI)

MDD
Changping Laboratory

Recruiting

pBFS Guided VS "5-cm Rule" rTMS Over DLPFC for MDD

Major Depression | MDD

China
Neuronetics
Columbia University; Brown University; Sheppard Pratt Health System; NAMSA; Southern... and other collaborators

Completed

Retrospective TMS Therapy for Adults With MDD

Major Depressive Disorder (MDD)
Mclean Hospital
National Institute of Mental Health (NIMH)

Completed

The Effects of Dopamine on Reward Processing

Major Depressive Disorder (MDD)

United States
AstraZeneca

Completed

European Drug Utilization Study (EUDUS)

Major Depressive Disorder (MDD)

Germany
University of California, Berkeley
National Institute of Mental Health (NIMH); Vanderbilt University

Completed

Improving Depression Outcome by Enhancing Memory for Cognitive Therapy

Major Depressive Disorder (MDD)

United States
GlaxoSmithKline

Completed

Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan

Major Depressive Disorder (MDD)

Japan
Duke University

Completed

Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With Vilazodone

Major Depressive Disorder (MDD)

United States
Shanghai Mental Health Center
Shanghai Innovative Research Center of Traditional Chinese Medicine

Unknown

Comparison of Yuxintine With Placebo in Treatment of MDD

Major Depressive Disorder (MDD)

China
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder

Major Depressive Disorder (MDD)

Korea, Republic of
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Completed

Light, Ion, and Fluoxetine Efficacy (LIFE) in Depression

Major Depressive Disorder (MDD)

Canada
University of British Columbia

Completed

The WORKER Study: Escitalopram and Telephone-based Cognitive Behaviour Therapy (CBT) for Depressed Working People

Major Depressive Disorder (MDD)

Canada
Philipps University Marburg Medical Center
Psychotherapie-Ambulanz Marburg e.V.

Completed

The Modulatory Role of Communicated Treatment Rationale on Treatment Expectation Effects in Depression.

Condition: Major Depressive Disorder (MDD)

Germany
Baylor College of Medicine
Icahn School of Medicine at Mount Sinai

Completed

Optimization of IV Ketamine for Treatment Resistant Depression

Major Depressive Disorder (MDD) | Treatment Resistant Depression (TRD)

United States
University of North Carolina, Chapel Hill
Foundation of Hope, North Carolina

Completed

Mechanism of Action of tACS for the Treatment of MDD (GLADIATOR2)

Major Depressive Disorder | MDD

United States
Stanford University

Completed

Extended Reality Behavioral Activation: An Intervention for Major Depressive Disorder

Depression | Major Depressive Disorder | MDD

United States
Stanford University

Completed

Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder

Depression | Major Depressive Disorder | MDD

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment

MDD

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Withdrawn

Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety

Major Depressive Disorder (MDD)
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

United States, Spain, Hungary, South Africa, Croatia, France, Poland, India, Canada, Sweden, Malaysia
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

Finland, Germany, Korea, Republic of, United States, Taiwan, Estonia, India, Italy, Mexico
Novartis

Completed

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

Major Depressive Disorder (MDD)

United States
Brainsway

Unknown

Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD)

Major Depressive Disorder (MDD)

United States, Canada, Israel
MSI Methylation Sciences, Inc.

Completed

Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

United States
Epix Pharmaceuticals, Inc.

Completed

A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder

Major Depressive Disorder (MDD)

United States
Clexio Biosciences Ltd.

Recruiting

A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder (SOLEO)

Adjunctive Treatment of Major Depressive Disorder (MDD)

United States
Otsuka Pharmaceutical Development & Commercialization...

Terminated

To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

United States, Australia, Bulgaria, Romania, India, Slovakia, Philippines
GlaxoSmithKline

Completed

Depression Study In Elderly Patients

Depressive Disorder, Major | Major Depressive Disorder (MDD)

United States
Baker Heart and Diabetes Institute
The Alfred; Monash Medical Centre; Servier Laboratories (Australia) Pty Ltd

Unknown

Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

Australia
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy

Major Depressive Disorder (MDD)

United States
GlaxoSmithKline

Completed

Study Of GW679769 In Major Depressive Disorder

Depressive Disorder, Major | Major Depressive Disorder (MDD)

United States, Canada
Rexahn Pharmaceuticals, Inc.

Completed

Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

United States
GlaxoSmithKline

Completed

An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder

Major Depressive Disorder (MDD)

United States
Changping Laboratory

Not yet recruiting

pBFS Guided rTMS Over Different Targets for Treatment-Resistant Depression

Major Depressive Disorder | Treatment Resistant Depression | MDD
Changping Laboratory

Recruiting

rTMS Therapy for Treatment-Resistant Depression With Different Targets Guided by pBFS

Major Depressive Disorder | Treatment Resistant Depression | MDD

China
Changping Laboratory

Recruiting

pBFS-Guided rTMS Therapy Over Different Targets for Treatment-Resistant Depression

Major Depressive Disorder | Treatment Resistant Depression | MDD

China
Changping Laboratory

Recruiting

pBFS Guided rTMS Therapy Over Different Targets for Treatment-Resistant Depression

Major Depressive Disorder | Treatment Resistant Depression | MDD

China
GlaxoSmithKline

Completed

Sexual Functioning Study With Antidepressants

Depressive Disorder, Major | Major Depressive Disorder (MDD)

United States

Clinical Trials on Major Depressive Disorder (MDD)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations